Anavex Life Sciences Corp (AVXL)

[nidan7500]

Bear...above and beyond as usual. IMO, he is "in your face" confident and he is making a statement about how past trials have been done and what will follow from here. All we have to decide is, is this guy incompetent (no-one/few who has studied his work would suggest that) . He is saying the results are spectacular and you must wait b/c we cannot describe yet what we think we have. It is that good. Trust me. So, either trust him or move on, no hard feelings and no drama.
I'm good with that assessment.

How does one make SENSE of the Company/CEO's above INACTIONS, all the while actually taking these next 5 ACTIONS?:
(1) starting an SEC regulated insider planned stock purchases plan for public visibility about 6 weeks ago (widely acknowledged as a likely show of confidence by the CEO), and
(2) continuing to make positive unambiguous efficacy assertions such as "provides dose dependent cognitive improvement" and "restores cellular homeostasis" in scientific and investor conference abstracts and p/r's to date, and
(3) continue to proclaim as recently as the August 2017 SEC quarterly filing that the 3 trials have been designed and are first of their kind in precision medicine (see quote below), and
(4) deciding to use the 12 month charts from Dec 2016 in June 2017 (positive charts) with older data than what they had in hand at that time in June 2017, and
(5) continue to sign up for upcoming scientific conferences such as tomorrow's 2017 Healthcare Conference and the 11/13 and 11/14 Neuroscience 2017 Conference